Millennium Management’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,468
Closed -$19.9K 6503
2025
Q3
$19.9K Buy
+1,468
New +$19.5K ﹤0.01% 5863
2025
Q2
Sell
-541
Closed -$6.17K 6362
2025
Q1
$6.17K Sell
541
-2,491
-82% -$29.7K ﹤0.01% 5707
2024
Q4
$36.4K Buy
+3,032
New +$40.7K ﹤0.01% 5638
2022
Q4
Sell
-1,224
Closed -$33K 7094
2022
Q3
$33K Sell
1,224
-955
-44% -$36.1K ﹤0.01% 6313
2022
Q2
$89K Sell
2,179
-659
-23% -$33.2K ﹤0.01% 5984
2022
Q1
$171K Sell
2,838
-293
-9% -$16.6K ﹤0.01% 5899
2021
Q4
$197K Sell
3,131
-36
-1% -$2.46K ﹤0.01% 5918
2021
Q3
$196K Sell
3,167
-10,594
-77% -$671K ﹤0.01% 6125
2021
Q2
$905K Buy
13,761
+12,861
+1,429% +$870K ﹤0.01% 4758
2021
Q1
$68K Buy
+900
New +$77.2K ﹤0.01% 5742
2020
Q2
Sell
-7,306
Closed -$454K 4630
2020
Q1
$454K Buy
+7,306
New +$609K ﹤0.01% 2946
2016
Q1
Sell
-536
Closed -$48K 3695
2015
Q4
$48K Sell
536
-807
-60% -$68.5K ﹤0.01% 3311
2015
Q3
$120K Buy
+1,343
New +$103K ﹤0.01% 3245

Other funds holding VNRX

Millennium Management's VNRX Position: Q4 2025 in Review

Millennium Management sold out of VolitionRx Ltd (VNRX) in Q4 2025, closing a stake of 1,468 shares — an estimated $19.9K sold.

Millennium Management first reported a position in VNRX in Q3 2015 and held it in 13 quarters. The position peaked at $905K in Q2 2021. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2025.

  • Millennium Management reported no remaining VolitionRx Ltd position as of Q4 2025 after selling out during the quarter.
  • Millennium Management sold 1,468 VolitionRx Ltd shares in Q4 2025, an estimated $19.9K.
  • Millennium Management first reported a position in VolitionRx Ltd in Q3 2015 and held it in 13 quarters.
  • Millennium Management's VolitionRx Ltd position peaked at $905K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2025.

Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.